Vaxart

Vaxart Current Ratio

Current Ratio of Vaxart (VXRT) as of Oct 24, 2026.

Current Ratio

-

Last updated:

Current Ratio of Vaxart is 2026 - . Current Ratio of Vaxart was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vaxart Stock analysis

What does Vaxart do? Vaxart Inc is a US biotechnology company that was founded in 2004 and is based in South San Francisco, California. The company specializes in the development of oral vaccines and therapeutics. Vaxart is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vaxart stock

On Eulerpool you can find the complete historical development of Current Ratio Vaxart since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Vaxart with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Vaxart

All Key Metrics — Vaxart